CHD5

Chr 1

chromodomain helicase DNA binding protein 5

Also known as: CHD-5, PMNDS

This gene encodes a member of the chromodomain helicase DNA-binding protein family. Members of this family are characterized by a chromodomain, a helicase ATP-binding domain and an additional functional domain. This gene encodes a neuron-specific protein that may function in chromatin remodeling and gene transcription. This gene is a potential tumor suppressor gene that may play a role in the development of neuroblastoma. [provided by RefSeq, Feb 2012]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.16
Clinical SummaryCHD5
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
42 unique Pathogenic / Likely Pathogenic· 427 VUS of 565 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.16LOEUF
pLI 1.000
Z-score 8.44
OE 0.09 (0.050.16)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
5.32Z-score
OE missense 0.56 (0.530.60)
668 obs / 1182.5 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios?
LoF OE?0.09 (0.050.16)
00.351.4
Missense OE?0.56 (0.530.60)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 9 / 100.2Missense obs/exp: 668 / 1182.5Syn Z: -0.05
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedCHD5-related neurodevelopmental disorder with intellectual disability, speech delay and epilepsyLOFAD

This gene — mechanism propensity

DN
0.4090th %ile
GOF
0.3887th %ile
LOF
0.65top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 50% of P/LP variants are LoF · LOEUF 0.16

Literature Evidence

LOFThompson et al. (2003) also noted that microdeletions in monosomy 1p36 syndrome would include the CHD5 gene, suggesting that haploinsufficiency of CHD5 may contribute to the neurologic and developmental problems seen in those patients.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 12592387

ClinVar Variant Classifications

565 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic34
VUS427
Likely Benign54
Benign19
Conflicting7
8
Pathogenic
34
Likely Pathogenic
427
VUS
54
Likely Benign
19
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
0
0
0
8
Likely Pathogenic
13
20
1
0
34
VUS
4
397
24
2
427
Likely Benign
0
13
8
33
54
Benign
0
1
8
10
19
Conflicting
7
Total254314145549

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

57 pathogenic / likely-pathogenic (of 65) ClinVar copy-number / structural variants overlap CHD5 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CHD5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →